INT-EN Medal_Excellence_Hero_image

Nobel Biocare announces new Medal of Excellence in Implant Dentistry – Nominations now open

Nobel Biocare announces new Medal of Excellence in Implant Dentistry – Nominations now open

Zurich, Switzerland – Nobel Biocare, a global leader in implant-based dental solutions, announces the launch of the Medal of Excellence in Implant Dentistry Award, a prestigious new accolade recognizing exceptional contributions to the field of implant dentistry.
Officially announced at the Nobel Biocare Global Symposium in Las Vegas, this new award is now open for submissions online, and will honor individuals or organizations who have led projects in one of two areas:

  • Innovation Advancing treatment solutions or protocols in the field of implant dentistry that can enable clinicians to treat more patients better.
  • Humanitarianism Improving the quality of life for people in need by providing dental implant treatments that extend beyond the usual scope of the daily practice.

The judging committee is chaired by Prof. Tomas Albrektsson, who has been a pioneer in dental implantology for almost 60 years, and was mentored by the inventor and founder of Nobel Biocare, Prof. P-I Brånemark.
Alongside Prof. Albrektsson, the committee consists of international expert clinicians, Prof. Joseph Kan (US), Dr. Chandur Wadhwani (US), Dr. Glen Liddelow (Australia), Prof. James Chow (China), Dr. Giacomo Fabbri (Italy), and Dr. Lesley David (Canada).

Stefan Nilsson, President of Nobel Biocare, emphasized the significance of the award:
"Nobel Biocare is proud to establish the Medal of Excellence in Implant Dentistry, a prestigious annual recognition honoring an individual who has made extraordinary contributions to the field of dental implantology. Each year, this exclusive recognition will celebrate either pioneering innovation or significant humanitarian service, ultimately improving patient care and advancing dentistry."
The runners-up of the award will be announced in December, and the winner will be announced in February 2026.
To submit a nomination for the Medal of Excellence, visit: https://www.nobelbiocare.com/en-int/medal-of-excellence
 

Media contacts

Media contacts – Nobel Biocare
Chris Kendall, Senior Manager Brand Communications, Nobel Biocare 
christopher.kendall@envistaco.com

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including Nobel Biocare N1™, NobelActive®, NobelParallel™, and the All-on-4® treatment concept), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), prefabricated prosthetics, and a wide variety of regenerative solutions (creos™). Products are supported by a single digital platform for imaging, diagnostics, and treatment planning (DTX Studio™ suite), and guided and navigated surgery (NobelGuide® and X-Guide®). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland, and production takes place at sites located in the United States and Sweden. Products and services are available in over 50 countries through subsidiaries and distributors. Nobel Biocare is part the Envista family, one of the largest global dental products companies with more than 30 trusted dental brands. For more information, please visit https://www.nobelbiocare.com.

Related articles

Nobel Biocare global symposium

Nobel Biocare announces full program of Global Symposium 2025

Feb 27, 2025

Zurich, Switzerland (February 27, 2025 ) — Nobel Biocare, a world leader in innovative implant-based dental solutions, is proud to announce its Global Symposium 2025, to be held from May 30–June 1, 2025, at the iconic Bellagio Hotel an